TZVI PALASH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protalix BioTherapeutics, Inc.

Filing Date Source Excerpt
2017-08-25 The following table sets forth information, as of August 10, 2017, regarding beneficial ownership of our common stock: Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage of Class (%) Board of Directors and Executive Officers Tzvi Palash
2017-09-01 Board of Directors and Executive Officers Tzvi Palash Consists of 102,000 outstanding shares of our common stock held and 238,125 shares of our common stock issuable upon exercise of outstanding options.

Data sourced from SEC filings. Last updated: 2026-02-08